Darbepoetin alfa biosimilar (Dong-A ST)

阿法达贝泊汀生物类似药 (Dong-A ST)

Report date: 2024/02/06 15:03:38

Base Information

Drug NameDarbepoetin alfa biosimilar (Dong-A ST)
Drug Alias Name达促红素α生物仿制药 (Dong-A ST)Darbepoetin alfa biosimilar(Kidswell Bio)Epoetin alfa biosimilar(Kidswell Bio)阿法达贝泊汀生物仿制药 (Dong-A ST)阿法达贝汀生物仿制药 (Dong-A ST) +[9] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Biosimilar
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemiaKidney Diseases
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2019/09/20
Country/TerritoryNetherlandsJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPolifarmaKidswell Bio CorpSanwa Kagaku Kenkyusho Co Ltd
Inactive CompaniesDong-A ST Co Ltd
Active IndicationsAnemiaKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeB03XA02
Related LinksN/A